Latest News and Press Releases
Want to stay updated on the latest news?
-
Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Global mRNA Cancer Vaccines Clinical Trials and Market Future Outlook 2024 Report Highlights: mRNA Cancer Vaccines In Clinical Trials: > 60...
-
Delhi, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Molecular Switches As Therapeutic Targets, Drug Development, Drug Delivery Mechanism & Application By Indications Insight 2025 Research Insights: Top 20...
-
Delhi, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development...
-
Delhi, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The recent approval of sacituzumab tirumotecan in China represents a significant advancement in oncology, particularly in the realm of targeted therapies....
-
Delhi, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Global Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028 Report Highlights: Global Targeted...
-
Delhi, Dec. 05, 2024 (GLOBE NEWSWIRE) -- GCC Pharmaceutical Market Opportunity & Clinical Trials Outlook 2030 Report Highlights: GCC Pharmaceutical Market Opportunity: > US$ 12 Billion By ...
-
Delhi, Nov. 25, 2024 (GLOBE NEWSWIRE) -- In November 2024, Jazz Pharmaceuticals announced that the US FDA granted accelerated approval for zanidatamab, a bispecific antibody, for the treatment of...
-
Delhi, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: Global Peptide Cancer Drug Market...
-
Delhi, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030 Report Finding & Inclusions: Global...
-
Delhi, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Global PROTAC Targeted Protein Degraders Market Opportunity & Clinical Trials Insight 2027 Report Finding & Inclusions: First PROTAC Drug...